Structure-function relationships of ErbB RTKs in the plasma membrane of living cells

Cold Spring Harbor Perspectives in Biology

Volumn 6, Issue 4, 2014, Pages

  Arndt Jovin, Donna J ^a   Botelho, Michelle G ^a   Jovin, Thomas M ^a  

^a MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

ONCOPROTEIN; PROTEIN AGGREGATE;

ANIMAL; CELL MEMBRANE; CHEMISTRY; MAMMAL; METABOLISM; PHYSIOLOGY; PSEUDOPODIUM; SIGNAL TRANSDUCTION; X RAY CRYSTALLOGRAPHY;

ANIMALS; CELL MEMBRANE; CRYSTALLOGRAPHY, X-RAY; MAMMALS; ONCOGENE PROTEINS V-ERBB; PROTEIN AGGREGATES; PSEUDOPODIA; SIGNAL TRANSDUCTION;

EID: 84908657323     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a008961     Document Type: Article

References (83)

1. Alexi X, Berditchevski F, Odintsova E. 2011. The effect of cell-ECM adhesion on signalling via the ErbB family of growth factor receptors. Biochem Soc Trans 39: 568–573.
2. Arkhipov A, Shan Y, Das R, Endres NF, Eastwood MP, Wemmer DE, Kuriyan J, Shaw DE. 2013. Architecture and membrane interactions of the EGF receptor. Cell 152: 557–569.
3. Barton WA, Dalton AC, Seegar TCM, Himanen JP, Nikolov DB. 2014. Tie2 and Eph receptor tyrosine kinase activation and signaling. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a009142.
4. Berger MB, Mendrola JM, Lemmon MA. 2004. ErbB3/ HER3 does not homodimerize upon neuregulin binding at the cell surface. FEBS Lett 569: 332–336.
5. Bharde AA, PalankarR, Fritsch C,Klaver A, Kanger JS, Jovin TM, Arndt-Jovin DJ. 2013. Magnetic nanoparticles as mediators of ligand-free activation of EGFR signaling. Plos ONE 8: e68879.
6. Bill HM, KnudsenB,Moores SL, Muthuswamy SK, Rao VR, Brugge JS, Miranti CK. 2004. Epidermal growth factor receptor-dependent regulation of integrin-mediated signaling and cell cycle entry in epithelial cells. Mol Cell Biol 24: 8586–8599.
7. Brock R, Jovin TM. 2003. Quantitative image analysis of cellular protein translocation induced by magnetic mi-crospheres: Application to the EGF receptor. Cytometry 52A: 1–11.
8. Brock R, Hamelers IHL, Jovin TM. 1999. Comparison of fixation protocols for adherent cultured cells applied to a GFP fusion protein of the epidermal growth factor receptor. Cytometry 35: 353–362.
9. Cho I, Cho HS, Mason K, Ramyar KX, Stanley AM, Gabelli SB, Denney DW Jr, Leahy DJ. 2003. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421: 756–760.
10. Chung I, Akita R, Vandlen R, Toomre D, Schlessinger J, Mellman I. 2010. Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature 464: 783–787.
11. Citri A, Skaria KB, Yarden Y. 2003. The deaf and the dumb: The biology of ErbB-2 and ErbB-3. Exp Cell Res 284: 54– 65.
12. Coskun U, Grzybek M, Drechsel D, Simons K. 2011. Regulation of human EGF receptor by lipids. Proc Natl Acad Sci 108: 9044–9048.
13. Digman MA, Dalal R, Horwitz AF, Gratton E. 2008. Mapping the number of molecules and brightness in the laser scanning microscope. Biophys J 94: 2320–2332.
14. Endres NF, Das R, Smith AW, Arkhipov A, Kovacs E, Huang Y, Pelton JG, Shan Y, Shaw DE, Wemmer DE, et al. 2013. Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell 152 543–556.
15. Ferguson KM, Berger MB, Mendrola JM, Cho HS, Leahy DJ, Lemmon MA. 2003. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimeriza-tion. Mol Cell 11: 507–517.
16. Friedländer E, Nagy P, Arndt-Jovin DJ, Jovin TM, Szöllösi J, Vereb G. 2005. Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: Local stimulation using magnetic microspheres as assessed by quantitative digital microscopy. Cytometry 67A: 161–171.
17. Gadella TWJ Jr, Jovin TM. 1995. Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy: A ster-eochemical model for tyrosine kinase receptor activation. J Cell Biol 129: 1543–1558.
18. Garcia-Morales P, Minami Y, Luong E, Klausner RD, Samel-son LE. 1990. Tyrosine phosphorylation in T cells is regulated by phosphatase activity: Studies with phenylarsine oxide. Proc Natl Acad Sci 87: 9255–9259.
19. Garrett TPJ, McKern NM, Lou MZ, EllemanTC, Adams TE, Lovrecz GO, Zhu HJ, Walker F, Frenkel MJ, Hoyne PA, et al. 2002. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor a. Cell 110: 763–773.
20. Garrett TPJ, McKern NM, Lou MZ, EllemanTC, Adams TE, Lovrecz GO, KoflerM, Jorissen RN, Nice EC, Burgess AW, et al. 2003. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. Mol Cell 11: 495–505.
21. George N. 2006. A new method for protein labeling with small molecules based on acyl carrier protein. Chemistry and chemical genetics, 149 pp. PhD thesis, École Polytechnique Fédérale de Lausanne, Lausanne.
22. Ghatak S, Misra S, Toole BP. 2005. Hyaluronan constitutive-ly regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J Biol Chem 280: 8875–8883.
23. Gilmour LMR, Macleod KG, McCaig A, Sewell JM, Gullick WJ, Smyth JF, Langdon SP. 2002. Neuregulin expression, function, and signaling in human ovarian cancer cells. Clin Cancer Res 8: 3933–3942.
24. Grecco HE, Roda-Navarro P, Girod A, Hou J, Frahm T, Truxius DC, Pepperkok R, Squire A, Bastiaens PI. 2010. In situ analysis of tyrosine phosphorylation networks by FLIM on cell arrays. Nat Methods 2010: 9.
25. Holbro T, Beerli RR, Maurer F, Koziczak M, Barbas CF, Hynes NE. 2003. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc Natl Acad Sci 100: 8933–8938.
26. Hunter T. 2014. The genesis of tyrosine phosphorylation. Cold Spring Harb Perspect Biol doi: 10.1101/cshper-spect.a020644.
27. Ieguchi K, Fujita M, Ma Z, Davari P, Taniguchi Y, Sekiguchi K, Wang BZ, Takada YK, Takada Y. 2010. Direct binding of the EGF-like domain of neuregulin-1 to integrins (avb3 and a6b4) is involved in neuregulin-1/ErbB signaling. J Biol Chem 285: 31388–31398.
28. Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kalyanaraman B, Finkel T, Stamler JS, Rhee SG, van der Vliet A. 2008. Redox-based regulation of signal trans-duction: Principles, pitfalls, and promises. Free Radic Biol Med 45: 1–17.
29. Jura N, Endres NF, Engel K, Deindl S, Das R, Lamers MH, Wemmer DE, Zhang X, Kuriyan J. 2009. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell 137: 1293–1307.
30. Kozer N, Henderson C, Jackson JT, Nice EC, Burgess AW, Clayton AH. 2011. Evidence for extended YFP-EGFR di-mers in the absenceof ligand on the surfaceof living cells. Phys Biol 8: 066002.
31. Kucherak OA, Oncul S, Darwich Z, Yushchenko DA, Arntz Y, DidierP, Mely Y, Klymchenko AS. 2010. Switchable nile red-based probe for cholesterol and lipid order at the outer leaflet of biomembranes. J Am Chem Soc 132: 4907–4916.
32. Kusumi A, Suzuki KG, Kasai RS, Ritchie K, Fujiwara TK. 2011. Hierarchical mesoscale domain organization of the plasma membrane. Trends Biochem Sci 36: 604–615.
33. Lee S-R, Kwon K-S, Kim S-R, Rhee SG. 1998. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273: 15366–15372.
34. Lemmon MA,BuZM, Ladbury JE, ZhouM,PinchasiD,Lax I, Engelman DM, Schlessinger J. 1997. Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J 16: 281–294.
35. Li S, Schmitz KR, Jeffrey PD, Wiltzius JJ, Kussie P, Ferguson KM. 2005. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell 7: 301–311.
36. Lidke DS, Nagy P, Heintzmann R, Arndt-Jovin DJ, Post JN, Grecco H, Jares-Erijman EA, Jovin TM. 2004. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat Biotechnol 22: 198–203.
37. Lidke DS, Lidke KA, Rieger B, Jovin TM, Arndt-Jovin DJ. 2005. Reaching out for signals: Filopodia sense EGF and respond by directed retrograde transport of activated receptors. J Cell Biol 170: 619–626.
38. Low-Nam ST, Lidke KA, Cutler PJ, Roovers RC, van Bergen en Henegouwen PMP, Wilson BS, Lidke DS. 2011. ErbB1 dimerization is promoted by domain co-confinement and stabilized by ligand binding. Nat Struct Mol Biol 18: 1244–1249.
39. Lu C, Mi LZ, Schurpf T, Walz T, Springer TA. 2012. Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptor. J Biol Chem 287: 38244– 38253.
40. Martin-Fernandez M, Clarke DT, Tobin MJ, Jones SV, Jones GR. 2002. Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling. Biophys J 82: 2415–2427.
41. Michailidis IE, Rusinova R, Georgakopoulos A, Chen Y, Iyengar R, Robakis NK, Logothetis DE, Baki L. 2011. Phosphatidylinositol-4,5-bisphosphate regulates epidermal growth factor receptor activation. Pflugers Arch 461: 387–397.
42. Moriki T, Maruyama H, Maruyama IN. 2001. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J Mol Biol 311: 1011–1026.
43. Nagy P, Bene L, Balazs M, Hyun WC, Lockett SJ, Chiang NY, Waldman F, Feuerstein BG, Damjanovich S, Szollosi J. 1998. EGF-induced redistribution of erbB2 on breast tumor cells: Flow and image cytometric energy transfer measurements. Cytometry 32: 120–131.
44. Nagy P, Jenei A, Kirsch AK, Szollosi J, Damjanovich S, Jovin TM. 1999. Activation-dependent clustering of the erbB2 receptor tyrosine kinase detected by scanning near-field optical microscopy. J Cell Sci 112: 1733–1741.
45. Nagy P, Vereb G, Sebestyen Z, Horvath G, Lockett SJ, Dam-janovich S,Park JW, Jovin TM, SzollosiJ. 2002. Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2. J Cell Sci 115: 4251–4262.
46. Nagy P, Friedländer E, Tanner M, Kapanen AI, Carraway KL, Isola J, Jovin TM. 2005. Decreased accessibility and lack of activation of erbB2 in JIMT-1, a Herceptin-resistant, MUC-4-expressing breast cancer cell line. Cancer Res 65: 473–482.
47. Nagy P, Claus J, Jovin TM, Arndt-Jovin DJ. 2010. Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis. Proc Natl Acad Sci 107: 16524– 16529.
48. OffterdingerM, Bastiaens PI. 2008. Prolonged EGFR signaling by ERBB2-mediated sequestration at the plasma membrane. Traffic 9: 147–155.
49. Offterdinger M, Georget V, Girod A, Bastiaens PI. 2004. Imaging phosphorylation dynamics of the epidermal growth factor receptor. J Biol Chem 279: 36972–36981.
50. Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim JH, Saito K, Sakamoto A, Inoue M, Shirouzu M, et al. 2002. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110: 775–787.
51. Ozcan F, Klein P, Lemmon MA, Lax I, Schlessinger J. 2006. On the nature of low- and high-affinity EGF receptors on living cells. 103: 5735–5740.
52. Park E, Baron R, Landgraf R. 2008. Higher-order association states of cellular ERBB3 probed with photo-cross-linkable aptamers. Biochemistry 47: 11992–12005.
53. Red Brewer M,Choi SH, Alvarado D, MoravcevicK, Pozzi A, Lemmon MA, Carpenter G. 2009. The juxtamembrane region of the EGF receptor functions as an activation domain. Mol Cell 34: 641–651.
54. Reynolds AR, Tischer C, Verveer PJ, Rocks O, Bastiaens PI. 2003. EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation. Nat Cell Biol 5: 447–453.
55. Rhee SG, Bae YS, Lee SR, Kwon J. 2000. Hydrogen peroxide: A key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000: e1.
56. Rubin I, Yarden Y. 2001. The basic biology of HER2. Ann Oncol 12: 3–8.
57. Saffarian S, Li Y, Elson EL, Pike LJ. 2007. Oligomerization of the EGF receptor investigated by live cell fluorescence intensity distribution analysis. Biophys J 93: 1021–1031.
58. Sako Y, Minoghchi S, Yanagida T. 2000. Single-molecule imaging of EGFR signalling on the surface of living cells. Nat Cell Biol 2: 168–172.
59. Salas-Vidal E, Lomeli H. 2004. Imaging filopodia dynamics in the mouse blastocyst. Dev Biol 265: 75–89.
60. Santos Mde S, Naal RM, Baird B, Holowka D. 2013. Inhibitors of PI(4,5)P2 synthesis reveal dynamic regulation of IgE receptor signaling by phosphoinositides in RBL mast cells. Mol Pharmacol 83: 793–804.
61. Schmitz KR, Ferguson KM. 2009. Interaction of antibodies with ErbB receptor extracellular regions. Exp Cell Res 315: 659–670.
62. Shibuya M. 2013. VEGFR and type-V RTK activation and signaling. Cold Spring Harb Perspect Biol doi: 10.1101/ cshperspect.a009092.
63. Smirnova T, Zhou ZN, Flinn RJ, Wyckoff J, Boimel PJ, Poz-zuto M, Coniglio SJ, Backer JM, Bresnick AR, Condeelis JS, et al. 2011. Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis. Oncogene 4: 275.
64. Song S, Rosen KM, Corfas G. 2013. Biological function of nuclear receptor tyrosine kinase action. Cold Spring Harb Perspect Biol 5: a009001.
65. Songtawee N, Gleeson MP, Choowongkomon K. 2013. Computational study of EGFR inhibition: Molecular dynamics studies on the active and inactive protein conformations. J Mol Model 19: 497–509.
66. Stamos J, Sliwkowski MX, Eigenbrot C. 2002. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem 277: 46265–46272.
67. SzabóA, Horváth G, SzöllŐsi J, Nagy P. 2008. Quantitative characterization of the large-scale association of ErbB1 and ErbB2 by flow cytometric homo-FRET measurements. Biophys J 95: 2086–2096.
68. Tanaka KA, Suzuki KG, Shirai YM, Shibutani ST, Miyahara MS, Tsuboi H, Yahara M, Yoshimura A, Mayor S, Fuji-wara TK, et al. 2010. Membrane molecules mobile even after chemical fixation. Nat Methods 7: 865–866.
69. Tynan CJ, Clarke DT, Coles BC, Rolfe DJ, Martin-Fernandez ML, Webb SE. 2012. Multicolour single molecule imaging in cells with near infrared dyes. PLoS ONE 7: e36265.
70. Tyson DR, Larkin S, Hamai Y, Bradshaw RA. 2003. PC12 cell activation by epidermal growth factor receptor: Role of autophosphorylation sites. Int J Dev Neurosci 21: 63–74.
71. Verveer PJ, Wouters FS, Reynolds AR, Bastiaens PI. 2000. Quantitative imaging of lateral ErbB1 receptor signal propagation in the plasma membrane. Science 290: 1567–1570.
72. Vivero-Pol L, George N, Krumm H, Johnsson K, Johnsson N. 2005. Multicolor imagingof cell surface proteins. J Am Chem Soc 127: 12770–12771.
73. Volinsky N, Kholodenko BN. 2013. Complexity of receptor tyrosine kinase signaling processing. Cold Spring Harb Perspect Biol 5: a009043.
74. Wang Z, Zhang L, Yeung TK, Chen X. 1999. Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation. Mol Biol Cell 10: 1621–1636.
75. Wang J, Boriskina SV, Wang H, Reinhard BM. 2011. Illuminating epidermal growth factor receptor densities on filopodia through plasmon coupling. ACS Nano 5: 6619– 6628.
76. Yang S, Raymond-Stintz MA, Ying W, Zhang J, Lidke DS, Steinberg SL, Williams L, Oliver JM, Wilson BS. 2007. Mapping ErbB receptors on breast cancercell membranes during signal transduction. J Cell Sci 120: 2763–2773.
77. Yarden Y, Schlessinger J. 1987. Self-phosphorylation of epidermal growth factor receptor: Evidence for a model of intermolecular allosteric activation. Biochemistry 26: 1434–1442.
78. Yin J, Lin A, Golan D, Walsh C. 2006. Site-specific protein labeling by Sfp phosphopantetheinyl transferase. Nat Protoc 1: 280–285.
79. Yoon SJ, Nakayama K, Hikita T, Handa K, Hakomori SI. 2006. Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor. Proc Natl Acad Sci 103: 18987– 18991.
80. Yu X, Miyamoto S, Mekada E. 2000. Integrin a2b1-depen-dent EGF receptor activation at cell-cell contact sites. J Cell Sci 113: 2139–2147.
81. Zacharias DA, Violin JD, Newton AC, Tsien RY. 2002. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 296: 913–916.
82. Zhang Y, Opresko L, Shankaran H, Chrisler WB, Wiley HS, Resat H. 2009. HER/ErbB receptor interactions and signaling patternsin human mammary epithelial cells. BMC Cell Biol 10: 78.
83. Ziomkiewicz I, Loman A, Klement R, Fritsch C, Klym-chenko A, Bunt G, Jovin TM, Arndt-Jovin DJ. 2013. Dynamic conformational transitions of the EGF receptor in living mammalian cells determined by FRETand fluorescence lifetime imaging microscopy. Cytometry A 83A: 794–805.